Senti, UCLA is a university research lab that used an autologous DC in their clinical trials that Dr. Linda Liau has confirmed was/is DCVax-L. We know there are other research labs/clinics that have used an autologous DC product in their vaccines that sounds exactly like the UCLA product and exactly like DCVax-L. So, do you believe these were also DCVax-L products used with or without NWBO consent?
When this debate surfaced on this board a year or so ago, I didn't initially compare UCLA's relationship to DCax-L to those of places like the Mayo clinic or Moffett center. I thought UCLA was different because NWBO in-licensed Dr. Liau's work from UCLA. Since dstock and others revealed these "other" places using DCVax-L- similar vaccines, there's been quite some controversy. But recently I took a step back and compared UCLA with the other clinical trials by other clinics/labs and have to wonder "what is the difference", other than that we in-licensed UCLA and we developed it into a commercial product? Afterall, we could any day in-license the work from Mayo and Moffitt or even the Czech Republic clinics?
I don't know if you've commented on this before, but I'd like to hear your opinion.
TIA, Senti! And thanks for all your work for this board and the longs!
Bullish
Market Data 
Markets 
AI
